How is Next-Generation Therapeutics Reshaping the Pompe Disease Treatment Space
The clinical approach to progressive lysosomal storage disorders is shifting rapidly due to breakthroughs in genetic engineering and target-specific molecular design. Historically, managing these debilitating neuromuscular conditions was restricted to palliative interventions that slowed down muscle wasting without addressing the foundational biochemical blockades. Today, advanced biochemical...
0 Comments 0 Shares 2 Views 0 Reviews